Last $9.12 USD
Change Today -0.03 / -0.33%
Volume 911.4K
HALO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - HALOZYME THERAPEUTICS INC (HALO)

Halozyme Therapeutics, Inc. to Report Q2, 2014 on Aug 11, 2014
CapIQ 08/11/2014 4:00 AM ET
Halozyme Therapeutics, Inc. to Report Q1, 2014 on May 12, 2014
CapIQ 08/11/2014 4:00 AM ET
Halozyme Therapeutics, Inc. to Report Q4, 2013 on Feb 27, 2014
CapIQ 08/11/2014 4:00 AM ET

2013 revenues at Halozyme Therapeutics, Inc. totaled $54.8M USD, while annual losses equaled $0.74 per share.

Quarterly Earnings & Estimates - HALOZYME THERAPEUTICS INC (HALO)

Actuals vs. Estimates for HALOZYME THERAPEUTICS INC HALO

Halozyme Therapeutics, Inc.'s Quarterly Earnings

Halozyme Therapeutics, Inc. reported 2nd quarter 2014 losses of $0.13 per share on 08/13/2014.

Annual Earnings & Estimates - HALOZYME THERAPEUTICS INC (HALO)

Actuals vs. Estimates for HALOZYME THERAPEUTICS INC HALO

Halozyme Therapeutics, Inc.'s Annual Earnings

Halozyme Therapeutics, Inc. reported annual 2013 losses of $0.74 per share on 03/1/2014.

Quarterly Revenues - HALOZYME THERAPEUTICS INC (HALO)

Actuals vs. Estimates for HALOZYME THERAPEUTICS INC HALO

Halozyme Therapeutics, Inc.'s Quarterly Revenues

Halozyme Therapeutics, Inc. had 2nd quarter 2014 revenues of $18.4M USD. This bettered the $14.4M USD consensus of the 4 analysts covering the company. This was 27.2% above the prior year's 2nd quarter results.

Annual Revenues - HALOZYME THERAPEUTICS INC (HALO)

Actuals vs. Estimates for HALOZYME THERAPEUTICS INC HALO

Halozyme Therapeutics, Inc.'s Annual Revenues

Halozyme Therapeutics, Inc. had revenues for the full year 2013 of $54.8M USD. This was 29.5% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HALO:US $9.12 USD -0.03

HALO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amphastar Pharmaceuticals Inc $10.22 USD -0.09
View Industry Companies
 

Industry Analysis

HALO

Industry Average

Valuation HALO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 19.2x
Price/Book 20.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 16.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HALOZYME THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.